Embleema (RWE) - ICO Details

  • RWE - Embleema ICO details,price, stage, bonus, team.
Overview
0
Embleema (RWE) Initial Coin Offering Logo
StatusInactive
HeadlineEmpowering Patients to Own Their Health Data
CategoryDrugs & Healthcare
Starting date10/10/2019
Ending date01/01/2020
WebsiteView Website
WhitepaperView Whitepaper
Links

Embleema ICO Summary

Embleema is bringing blockchain solution in the Drugs & Healthcare industry.

Embleema initial coin offering will be held from October 10, 2019. RWE will be offered to investors until January 1, 2020.

A total of 500,000,000 RWE will be created and 150,000,000 will be available during the coin offering.
RWE coin/token sale will be considered successful if their softcap of 2,000,000(USD) is reached. Please keep in mind that the sale could end before January 1, 2020 if the hardcap of 30,000,000(USD) is reached.

During Embleema ICO, investors will be able to buy RWE at 0.2 USD per Coin/Token.

Get all the details about Embleema below and on Embleema Official ICO website

What is Embleema

Embleema’s blockchain network offers a novel way to put patients at the center of clinical research by letting them own their health data, disrupting the slow, costly, manual and opaque process by which low quality health data is currently collected by pharmaceutical companies through Contrat Research Organisation, to monitor the efficacy of new investigational drugs.

Connecting patients directly to medical research and incentivizing them to share their data with tokens, blockchain is the decentralized technology everyone was waiting for to move away from the current linear process of drug approvals, to a new iterative model where trustworthy digital health data is shared in real time between patients, life sciences and regulators.

The 21st Century Cures Act (2016) gave the FDA a mandate to accelerate approvals if more patient real world data was shared proactively by pharma. Embleema’s blockchain speeds up this process with patient buy-in, accelerating time to market new drugs.

RWE ICO Details

RWE Tokenomics & ICO Information
Softcap2,000,000(USD)
Hardcap30,000,000(USD)
USA accepted
Currency AcceptedBTC,ETH
Coin SymbolRWE
Total Coins500,000,000
Coins for Sale150,000,000
Private-Sale/Pre-Mined Coins0
Coins Sold%
Coin Price0.2 USD
Softcap Reached
Confirmed Exchange
Unsold Coins Goes to

Stage Details

Embleema

Embleema Stage Information & Bonus
Start date10/10/2019
End date01/01/2020
Token for sale150,000,000
Token Price0.2 USD

Team Info

Core Team

Dr. Vahan Simonyan

Chief Scientific Advisor, former R&D Director of Bioinformatics at the FDA

Pr. John Halamka, MD

CIO of Beth Israel, Pr. of Innovation at Harvard

Bernard Gilly, PhD

CEO of iBionext - Pixum -

Frédéric Duchesne, Pharm.D

CEO of Pierre Fabre Pharmaceuticals

Adel B. Al-Saleh

CEO T-Systems

Discuss about RWE

Please Login to join the discussion
  Subscribe  
Notify of
Featured ICOs
There are No Featured ICOs right now
3Commas Square
Recently Viewed ICO
Announcement

Facebook group ICL
Join our Newsletter

 

Don't miss out!

Get discounts on ICOs & Blockchain products + Receive the latest News, Updates & PR from ICL.